Monday 23 Jun, 2025 12:19 PM
Site map | Locate Us | Login
   Ideaforge Technology Ltd leads gainers in 'A' group    NSE SME Samay Project Services assembles a steady market entry    Avantel gains after bagging orders worth Rs 25 cr    Waaree Renewable tech signs MoU with Viet Khanh for 100 MW Solar EPC project    Crisil Ratings upgrades ratings of Netweb Technologies to 'A/A1' with 'stable' outlook    CareEdge Ratings reaffirms ratings of Tarsons Products with 'stable' outlook    NSE SME Patil Automation drives a stellar market entry    Bharat Electronics gains after securing additional orders worth Rs 585 cr    Zen Tech jumps after board nod to acquire majority stake in TISA Aerospace    Embassy Developments rises after inking joint development pact for land parcel in Bengaluru    Volumes jump at Dixon Technologies (India) Ltd counter    NLC India gains after renewables arm secures BESS project in Tamil Nadu    Meghna Infracon inks pact for re-developing residential project at Prabhadevi    Godrej Properties sells over Rs 2,000 cr inventory in Barca @ Godrej MSR city launch    Interarch Building gains on bagging Rs 80-cr order from Ather Energy 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Glenmark pharma's US facility receives five observations after USFDA GMP inspection
18-Jun-25   09:51 Hrs IST

According to a regulatory filing by the company, the USFDA conducted a good manufacturing practices (GMP) inspection at the Monroe site from 9 June to 17 June 2025. Following the conclusion of the inspection, the USFDA has issued a Form 483 with five observations. Glenmark clarified that all the observations are procedural in nature and none pertain to data integrity.

The company stated that it will work closely with the USFDA to address the observations and will submit its response within the stipulated timeline.

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

On a consolidated basis, Glenmark Pharmaceuticals reported net profit of Rs 4.65 crore in Q4 March 2025 as against net loss of Rs 1,218.28 crore in Q4 March 2024. Net sales rose 6.77% year-on-year to Rs 3220.13 crore in Q4 March 2025.

The counter shed 0.30% to Rs 1,648.80 on the BSE.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 42150217
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited